BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15941822)

  • 1. Severe hyperglycemia during renally adjusted gatifloxacin therapy.
    Blommel AL; Lutes RA
    Ann Pharmacother; 2005; 39(7-8):1349-52. PubMed ID: 15941822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature.
    Yip C; Lee AJ
    Clin Ther; 2006 Nov; 28(11):1857-66. PubMed ID: 17213006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.
    Lodise T; Graves J; Miller C; Mohr JF; Lomaestro B; Smith RP
    Pharmacotherapy; 2007 Nov; 27(11):1498-505. PubMed ID: 17963459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gatifloxacin-induced histamine release and hyperglycemia in rats.
    Ishiwata Y; Yasuhara M
    Eur J Pharmacol; 2010 Oct; 645(1-3):192-7. PubMed ID: 20674567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible gatifloxacin-induced hyperglycemia.
    Donaldson AR; Vandiver JR; Finch CK
    Ann Pharmacother; 2004 Apr; 38(4):602-5. PubMed ID: 14982977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: a retrospective, nested case-controlled analysis.
    Mohr JF; Peymann PJ; Troxell E; Lodise TP; Ostrosky-Zeichner L
    Clin Ther; 2008 Jan; 30(1):152-7. PubMed ID: 18343251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and gatifloxacin: a case report and summary of current literature.
    Beste LA; Mersfelder TL
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):262-5. PubMed ID: 16503322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing age and renal impairment as important predisposing factors of gatifloxacin-induced hyperglycemia in non-diabetes patients.
    Ovartlarnporn M; Jongjaroenprasert W
    J Med Assoc Thai; 2007 Mar; 90(3):569-73. PubMed ID: 17427537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.
    LeBlanc M; BĂ©langer C; Cossette P
    Pharmacotherapy; 2004 Jul; 24(7):926-31. PubMed ID: 15303456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
    Mohr JF; McKinnon PS; Peymann PJ; Kenton I; Septimus E; Okhuysen PC
    Pharmacotherapy; 2005 Oct; 25(10):1303-9. PubMed ID: 16185173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gatifloxacin-induced dysglycemia.
    Zvonar R
    Am J Health Syst Pharm; 2006 Nov; 63(21):2087-92. PubMed ID: 17057046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hyperglycemia during gatifloxacin therapy in patients without diabetes.
    Arce FC; Bhasin RS; Pasmantier R
    Endocr Pract; 2004; 10(1):40-4. PubMed ID: 15251620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible gatifloxacin-induced hypoglycemia.
    Baker SE; Hangii MC
    Ann Pharmacother; 2002 Nov; 36(11):1722-6. PubMed ID: 12398567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gatifloxacin-induced severe hyperglycaemia and ketoacidosis in a non-diabetic renal transplant recipient.
    Khaira A; Gupta A; Tandon N; Agarwal SK
    Clin Exp Nephrol; 2009 Feb; 13(1):89-91. PubMed ID: 18648734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride.
    Kesavadev J; Rasheed SA
    J Assoc Physicians India; 2006 Dec; 54():951-2. PubMed ID: 17334014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient gatifloxacin therapy and dysglycemia in older adults.
    Park-Wyllie LY; Juurlink DN; Kopp A; Shah BR; Stukel TA; Stumpo C; Dresser L; Low DE; Mamdani MM
    N Engl J Med; 2006 Mar; 354(13):1352-61. PubMed ID: 16510739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
    LaPlante KL; Mersfelder TL; Ward KE; Quilliam BJ
    Pharmacotherapy; 2008 Jan; 28(1):82-9. PubMed ID: 18154478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the effects of gatifloxacin on glucose homeostasis.
    Onyenwenyi AJ; Winterstein AG; Hatton RC
    Pharm World Sci; 2008 Oct; 30(5):544-9. PubMed ID: 18297409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study.
    Graumlich JF; Habis S; Avelino RR; Salverson SM; Gaddamanugu M; Jamma K; Aldag JC
    Pharmacotherapy; 2005 Oct; 25(10):1296-302. PubMed ID: 16185172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe dysglycemia with the fluoroquinolones: a class effect?
    Aspinall SL; Good CB; Jiang R; McCarren M; Dong D; Cunningham FE
    Clin Infect Dis; 2009 Aug; 49(3):402-8. PubMed ID: 19545207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.